<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04069104</url>
  </required_header>
  <id_info>
    <org_study_id>20190153</org_study_id>
    <nct_id>NCT04069104</nct_id>
  </id_info>
  <brief_title>Whack-a-Mole: Testing an Intervention to Increase Melanoma Identification</brief_title>
  <official_title>Whack-a-Mole: Testing an Intervention to Increase Melanoma Identification</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate an interactive game designed to increase people's
      ability to identify cancerous moles.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mole identification accuracy</measure>
    <time_frame>Day 2</time_frame>
    <description>Mole identification accuracy will be reported as the amount of mole correctly identified as either melanoma or typical nevi</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Skin Self Exam Intentions</measure>
    <time_frame>Day 2</time_frame>
    <description>Self-report measure of intentions to perform a skin self exam. Quantified using a single item indicator with scores ranging from 1-7 with higher scores indicating greater intentions to perform a skin self exam to detect potential melanomas.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intentions to see a Dermatologist</measure>
    <time_frame>Day 2</time_frame>
    <description>Self-report measure of intentions to schedule an appointment with a dermatologist to receive a skin cancer exam. Quantified using a single item indicator with scores ranging from 1-7 with higher scores indicating greater intentions to schedule an appointment with a dermatologist.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Skin Self Exam Attitudes</measure>
    <time_frame>Day 2</time_frame>
    <description>Self-report measure of attitudes towards skin cancer exams. Quantified using the mean of the self report scale with scores ranging from 1-7 with higher scores indicating more positive attitudes towards skin self exams.</description>
  </secondary_outcome>
  <number_of_groups>12</number_of_groups>
  <enrollment type="Anticipated">900</enrollment>
  <condition>Diagnoses Disease</condition>
  <arm_group>
    <arm_group_label>ABCD training with standard feedback</arm_group_label>
    <description>Asymmetry, Border, Color, Diameter (ABCD) training message intervention with standard dermatological feedback</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ABCD training with motivational feedback</arm_group_label>
    <description>ABCD training message intervention with dermatological feedback and a motivational message</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ABCD training with no feedback</arm_group_label>
    <description>ABCD message intervention with no feedback</description>
  </arm_group>
  <arm_group>
    <arm_group_label>UDS method training with standard feedback</arm_group_label>
    <description>Ugly Duckling Sign (UDS) method message intervention with dermatological feedback.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>UDS method training with motivational feedback</arm_group_label>
    <description>UDS message intervention with dermatological feedback and a motivational message.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>UDS training with no feedback</arm_group_label>
    <description>UDS message intervention with no feedback.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ABCD and UDS trainings with standard feedback</arm_group_label>
    <description>Both message interventions with dermatological feedback.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ABCD and UDS trainings with motivational feedback</arm_group_label>
    <description>Both message interventions with dermatological feedback and a motivational message.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ABCD and UDS trainings with no feedback</arm_group_label>
    <description>Both message interventions with no feedback.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No message intervention with standard feedback</arm_group_label>
    <description>No message intervention, but with dermatological feedback.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No message intervention with motivational feedback</arm_group_label>
    <description>No message intervention, but with dermatological feedback and a motivational message.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No message intervention with no feedback</arm_group_label>
    <description>No message intervention and no feedback. True control.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>ABCD Information</intervention_name>
    <description>The intervention condition includes exposure to a message emphasizing the ABCD strategy to identify malignant melanoma.</description>
    <arm_group_label>ABCD and UDS trainings with motivational feedback</arm_group_label>
    <arm_group_label>ABCD and UDS trainings with no feedback</arm_group_label>
    <arm_group_label>ABCD and UDS trainings with standard feedback</arm_group_label>
    <arm_group_label>ABCD training with motivational feedback</arm_group_label>
    <arm_group_label>ABCD training with no feedback</arm_group_label>
    <arm_group_label>ABCD training with standard feedback</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>UDS information</intervention_name>
    <description>The intervention condition includes exposure to a message emphasizing the UDS strategy to identify malignant melanoma.</description>
    <arm_group_label>ABCD and UDS trainings with motivational feedback</arm_group_label>
    <arm_group_label>ABCD and UDS trainings with no feedback</arm_group_label>
    <arm_group_label>ABCD and UDS trainings with standard feedback</arm_group_label>
    <arm_group_label>UDS method training with motivational feedback</arm_group_label>
    <arm_group_label>UDS method training with standard feedback</arm_group_label>
    <arm_group_label>UDS training with no feedback</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Standard (clinical) feedback</intervention_name>
    <description>Feedback on mole identification task provided by a dermatologist.</description>
    <arm_group_label>ABCD and UDS trainings with standard feedback</arm_group_label>
    <arm_group_label>ABCD training with standard feedback</arm_group_label>
    <arm_group_label>No message intervention with standard feedback</arm_group_label>
    <arm_group_label>UDS method training with standard feedback</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Motivational feedback</intervention_name>
    <description>Feedback on mole identification task provided by a dermatologist plus exposure to a motivational fear appeal message designed to increase skin self exam intentions.</description>
    <arm_group_label>ABCD and UDS trainings with motivational feedback</arm_group_label>
    <arm_group_label>ABCD training with motivational feedback</arm_group_label>
    <arm_group_label>No message intervention with motivational feedback</arm_group_label>
    <arm_group_label>UDS method training with motivational feedback</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adults living in U.S. who are members of the online panel.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Resident of U.S.

          -  At least 18 years old

          -  Capable of reading English

          -  Member of panel assembled by survey provider

        Exclusion Criteria:

          -  Individuals under 18 years old
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicholas Carcioppolo, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Study Co-Principal Investigator</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Soyoon Kim, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Study Co-Principal Investigator</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nicholas Carcioppolo, PhD</last_name>
    <phone>305-284-5633</phone>
    <email>n.carcioppolo@Miami.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Coral Gables</city>
        <state>Florida</state>
        <zip>33146</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Nicholas Carcioppolo, PhD</last_name>
      <phone>305-284-5633</phone>
      <email>n.carcioppolo@miami.edu</email>
    </contact>
    <investigator>
      <last_name>Nicholas Carcioppolo, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>August 23, 2019</study_first_submitted>
  <study_first_submitted_qc>August 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2019</study_first_posted>
  <last_update_submitted>March 18, 2020</last_update_submitted>
  <last_update_submitted_qc>March 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Nicholas Carcioppolo</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Melanoma identification</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melanoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

